Emcure Pharmaceuticals Ltd is scheduled to hit the market on July 03, 2024 and close on July 05, 2024. Emcure Pharmaceuticals Ltd plans to raise around ₹1952.03 Cr through an IPO with a sale of up to 1,93,65,347 equity shares with a face value of ₹10 each. The Retail offered 35%, QIB Shares Offered 50%, HNI Shares Offered 15%.
emcure pharma ltd. iPO GMP (gray market premium)
| GMP Date | IPO Price | GMP | Expected Listing Gain | Last Updated |
|---|---|---|---|---|
| 2 July 2024 | ₹960-₹1008 | ₹297 | ₹1305(29.46%) | 2 July 4:30 PM |
emcure pharma ltd. IPO – Important Dates
| IPO Activity | Date |
|---|---|
| IPO Open Date* | 3rd July 2024 |
| IPO Close Date* | 5th July 2024 |
| Basis of Allotment Date* | 8th July 2024 |
| Refunds Initiation* | 9th July 2024 |
| Credit of Shares to Demat* | 9th July 2024 |
| IPO Listing Date* | 10th July 2024 |
emcure pharma ltd. IPO – Lots Size & price
| Application | Lots | Share | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 14 | ₹14,112 |
| Retail (Max) | 14 | 196 | ₹1,97,568 |
| S-HNI (Min) | 15 | 210 | ₹2,11,680 |
| S-HNI (Max) | 70 | 980 | ₹9,87,840 |
| B-HNI (Min) | 71 | 994 | ₹10,01,952 |